Conferences on January 24, 2013

Social Media in the Pharmaceutical Industry

Date: 23-Jan-13 to 24-Jan-13
Location: London / United Kingdom
SMi Group is proud to present the 5th conference in their highly successful series of Social Media in the Pharmaceutical Industry this January that will allow companies to focus on how to improve their existing social media strategies, how to innovate into the new and emerging techniques and technologies and enhancing their company’s engagement potential. We are excited to also feature talks from key companies in the industry, including Google, Pfizer, UCB Pharma and Bayer, and will focus on case studies from the industry, techniques for social media use and implementation of social media mechanisms. Key reasons to attend include: • Speak with the key opinion leaders of the industry about the future of social media, digital pharma, e-marketing and regulations • Hear about the ...

Quality by Design

Date: 23-Jan-13 to 24-Jan-13
Location: London / United Kingdom
SMi are proud to present their inaugural Quality by Design Conference. With increasing pressure to reduce overheads and enhance clinical effectiveness, QbD permits improvements during development and manufacturing to be identified before production starts. Through the strategic use of risk management and PAT, we can also save time, money and increase regulatory and business opportunities. The earlier these are implemented, the cheaper and more effective they are. Covering QbD as an end-to-end process for pharmaceuticals and biotherapeutics, attending SMi’s innovative two-day conference will enable you to: • Refine and enhance a product's critical quality attributes • Develop a better manufacturing process design space • Employ QbD to design a formulation process • Utilise PAT ...

3rd Annual Global Mining Forum

Date: 23-Jan-13 to 24-Jan-13
Location: London / United Kingdom
3rd Annual Global Mining Forum 2013 will focus on economic uncertainties that remain prevalent and significantly impact the mining sector and consequently drive the industry to address several opportunities and challenges like: resource nationalism, raising costs, access to capital and socio - political environment. Exponent speakers and industry leaders will brainstorm over 10 sessions, intriguing panel discussion and relate case studies. This forum will give the participants a platform to interact, learn and collect business intelligence and strategic insight.

cGMP: Strategies for implementation and compliance for Phase I Investigational Drug and Biologic products

Date: 24-Jan-13 to 24-Jan-13
This cGMP training will help you in understanding systematic plan of evaluating cGMP applicable to the IND product cycle, the regulatory mandates (FDA, ICH, CHMP and the EU medicine agency), risk-management strategy and potential consequences for failures in inadequate assessment, and case studies of infractions Why Should You Attend: cGMP guide lines were formulated for the purpose of regulating large-scale manufacturing and commercial drug products. But it is amended in 21 CFR Part 210 for applicability to small-scale laboratory production of exploratory and investigational drug and biologic products. The amended GMP guide lines are a component of the FDA’s “Product Quality for the 21st Century” initiative for a selective approach to varying production objectives during drug ...

3-hr Virtual Seminar: OSHA Compliance Strategies for Auditing and Training Programs

Date: 24-Jan-13 to 24-Jan-13
This OSHA compliance training will highlight the reasons for OSHA Inspections and discuss methods to be ready for a surprise inspection at any time. You will learn how to evaluate your safety program, improve the quality and function of your safety committee and be prepared to deal with an OSHA Inspection.

Pestana Chelsea Bridge Hotel

Date: 22-Jan-13 to 24-Jan-13
Location: London / United Kingdom
SSON (45 sites) European Procurement Transformation Summit 2013 will address key topics throughout transformation project lifecycle: P2P process, compliance optimisation, automation & spend analytics…

2nd Annual Solvency II Summit

Date: 24-Jan-13 to 25-Jan-13
Location: Amsterdam / Netherlands
Solvency II is hanging over the insurance industry like the sword of Damocles, promising a violent reshaping of the whole industry. But will the change be truly as dramatic as prophesied? “Wait and see” is becoming the new attitude of the insurers, they are waiting for the regulatory debate to settle before finalising design, at the same time they are still trying to maintain a proactive stance to avoid back loading all development. Is 1 January 2014 going to be the final implementation date? Can Solvency II prevent another economic crisis or are we going to see Solvency III soon? Event Focus • Get the latest updates on the current state of Solvency II • Find out what you do not know about the three Pillars yet • Compare your preparedness with other major insurers • Get ...

CHI’s PepTalk: The Protein Science Week

Date: 21-Jan-13 to 25-Jan-13
Location: United States
CHI's PepTalk: The Protein Science Week is more than just a conference. It is a community dedicated to the evolving field of biotherapeutics and a gateway to the future of biologics. The continuous growth and success of PepTalk is due to the commitment and quality of scientific programming. Join us January 21-25 in Palm Springs, California to learn about the advances and debate the challenges in protein-based therapeutics.

3rd Annual Developing CAPAs in the GCP Environment

Date: 24-Jan-13 to 25-Jan-13
ExL Pharma is pleased to offer the 3rd Developing CAPAs in the GCP Environment Conference, taking place January 24-25 in Arlington, VA. As the ONLY forum dedicated to clinical corrective and preventive actions, this event has become the annual gathering for clinical quality and operations professionals from companies of all sizes and types to discuss and share their experiences with understanding, defining, developing and implementing clinical CAPAs.

5th Risk Evaluation and Mitigation Strategies Summit

Date: 24-Jan-13 to 25-Jan-13
The 5th Risk Evaluation and Mitigation Strategies Summit brings together executives from the industry to prepare for the changing landscape of REMS. As the 5th year anniversary of the FDAA Act of 2007, which mandated the implementation of REMS, arrives and brings forth new challenges, stay ahead of the curve and learn cutting-edge strategies and innovative techniques to ensure that your drugs are staying compliant while ensuring accessibility and success in the market. By attending this year’s event, you will benefit from one of the only conferences focused specifically on REMS and the strategies on how to design and implement a thorough risk management program that meets FDA regulations. Hear from experienced professionals the best practices to create a successful REMS assessment and ...